In Vivo Analysis of Lrig Genes Reveals Redundant and Independent Functions in the Inner Ear

PLoS Genetics

Volumn 9, Issue 9, 2013, Pages

  del Rio, Tony ^a   Nishitani, Allison M ^a   Yu, Wei Ming ^a   Goodrich, Lisa V ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUDITORY RESPONSE; COCHLEAR INNERVATION; CONTROLLED STUDY; EPITHELIUM; GENE; GENE DISRUPTION; GENE EXPRESSION; GENE FUNCTION; GENETIC ANALYSIS; IN VIVO STUDY; INNER EAR DEVELOPMENT; INNERVATION; LRIG GENE; LRIG1 GENE; LRIG2 GENE; LRIG3 GENE; MORPHOGENESIS; MOUSE; MOUSE MUTANT; NERVE CELL; NONHUMAN; ORGANOGENESIS; OTIC EPITHELIUM; PHENOTYPE; SENSITIVITY ANALYSIS; SENSORY EPITHELIA; SENSORY SYSTEM; VESTIBULAR SYSTEM;

ANIMALS; CYTOPLASM; EAR, INNER; EPIDERMAL GROWTH FACTOR; EPITHELIUM; GENE EXPRESSION REGULATION; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; MORPHOGENESIS; MUTATION; NERVE TISSUE PROTEINS; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION; VESTIBULE, LABYRINTH;

EID: 84884683694     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1003824     Document Type: Article

References (47)

1. Bella J, Hindle KL, McEwan PA, Lovell SC, (2008) The leucine-rich repeat structure. Cell Mol Life Sci 65: 2307-2333.
2. de Wit J, Hong W, Luo L, Ghosh A, (2011) Role of leucine-rich repeat proteins in the development and function of neural circuits. Annu Rev Cell Dev Biol 27: 697-729.
3. Dolan J, Walshe K, Alsbury S, Hokamp K, O'Keeffe S, et al. (2007) The extracellular leucine-rich repeat superfamily; a comparative survey and analysis of evolutionary relationships and expression patterns. BMC Genomics 8: 320.
4. Matsushima N, Tachi N, Kuroki Y, Enkhbayar P, Osaki M, et al. (2005) Structural analysis of leucine-rich-repeat variants in proteins associated with human diseases. Cell Mol Life Sci 62: 2771-2791.
5. Kobe B, Kajava AV, (2001) The leucine-rich repeat as a protein recognition motif. Curr Opin Struct Biol 11: 725-732.
6. Ng AC, Eisenberg JM, Heath RJ, Huett A, Robinson CM, et al. (2011) Human leucine-rich repeat proteins: a genome-wide bioinformatic categorization and functional analysis in innate immunity. Proc Natl Acad Sci U S A 108 Suppl 1: 4631-4638.
7. Maness PF, Schachner M, (2007) Neural recognition molecules of the immunoglobulin superfamily: signaling transducers of axon guidance and neuronal migration. Nat Neurosci 10: 19-26.
8. Volkmer H (2001) The immunoglobulin superfamily of cell adhersion. In: Beckerle MC, editor. Cell Adhesion. New York: Oxford University Press. pp. 1-29.
9. Chen Y, Aulia S, Li L, Tang BL, (2006) AMIGO and friends: an emerging family of brain-enriched, neuronal growth modulating, type I transmembrane proteins with leucine-rich repeats (LRR) and cell adhesion molecule motifs. Brain Res Rev 51: 265-274.
10. Homma S, Shimada T, Hikake T, Yaginuma H, (2009) Expression pattern of LRR and Ig domain-containing protein (LRRIG protein) in the early mouse embryo. Gene Expr Patterns 9: 1-26.
11. MacLaren CM, Evans TA, Alvarado D, Duffy JB, (2004) Comparative analysis of the Kekkon molecules, related members of the LIG superfamily. Dev Genes Evol 214: 360-366.
12. Ghiglione C, Carraway KL, (1999) The transmembrane molecule kekkon 1 acts in a feedback loop to negatively regulate the activity of the Drosophila EGF receptor during oogenesis. Cell 96: 847-856.
13. Hedman H, Henriksson R, (2007) LRIG inhibitors of growth factor signalling- double-edged swords in human cancer? Eur J Cancer 43: 676-682.
14. Guo D, Holmlund C, Henriksson R, Hedman H, (2004) The LRIG gene family has three vertebrate paralogs widely expressed in human and mouse tissues and a homolog in Ascidiacea. Genomics 84: 157-165.
15. Wang Y, Poulin EJ, Coffey RJ, (2013) LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor. Br J Cancer 108: 1765-1770.
16. Gur G, Rubin C, Katz M, Amit I, Citri A, et al. (2004) LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation. Embo J 23: 3270-3281.
17. Laederich MB, Funes-Duran M, Yen L, Ingalla E, Wu X, et al. (2004) The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases. J Biol Chem 279: 47050-47056.
18. Rafidi H, Mercado F, Astudillo M, Fry WH, Saldana M, et al. (2013) Leucine-rich repeat and immunoglobulin domain-containing protein-1 negative (Lrig1) regulatory action towards ErbB receptor tyrosine kinases is opposed by Leucine-rich repeat and immunoglobulin domain-containing protein-3 (Lrig3). J Biol Chem 288: 21593-605.
19. Jensen KB, Watt FM, (2006) Single-cell expression profiling of human epidermal stem and transit-amplifying cells: Lrig1 is a regulator of stem cell quiescence. Proc Natl Acad Sci U S A 103: 11958-11963.
20. Wong VW, Stange DE, Page ME, Buczacki S, Wabik A, et al. (2012) Lrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signalling. Nat Cell Biol 14: 401-408.
21. Powell AE, Wang Y, Li Y, Poulin EJ, Means AL, et al. (2012) The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Cell 149: 146-158.
22. Suzuki Y, Miura H, Tanemura A, Kobayashi K, Kondoh G, et al. (2002) Targeted disruption of LIG-1 gene results in psoriasiform epidermal hyperplasia. FEBS Lett 521: 67-71.
23. Shattuck DL, Miller JK, Laederich M, Funes M, Petersen H, et al. (2007) LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy. Mol Cell Biol 27: 1934-1946.
24. Ledda F, Bieraugel O, Fard SS, Vilar M, Paratcha G, (2008) Lrig1 is an endogenous inhibitor of Ret receptor tyrosine kinase activation, downstream signaling, and biological responses to GDNF. J Neurosci 28: 39-49.
25. Abraira VE, Satoh T, Fekete DM, Goodrich LV, (2010) Vertebrate Lrig3-ErbB interactions occur in vitro but are unlikely to play a role in Lrig3-dependent inner ear morphogenesis. PLoS One 5: e8981.
26. Cai M, Han L, Chen R, Ye F, Wang B, et al. (2009) Inhibition of LRIG3 gene expression via RNA interference modulates the proliferation, cell cycle, cell apoptosis, adhesion and invasion of glioblastoma cell (GL15). Cancer Lett 278: 104-112.
27. Zhao H, Tanegashima K, Ro H, Dawid IB, (2008) Lrig3 regulates neural crest formation in Xenopus by modulating Fgf and Wnt signaling pathways. Development 135: 1283-1293.
28. Abraira VE, Del Rio T, Tucker AF, Slonimsky J, Keirnes HL, et al. (2008) Cross-repressive interactions between Lrig3 and netrin 1 shape the architecture of the inner ear. Development 135: 4091-4099.
29. Wang B, Han L, Chen R, Cai M, Han F, et al. (2009) Downregulation of LRIG2 expression by RNA interference inhibits glioblastoma cell (GL15) growth, causes cell cycle redistribution, increases cell apoptosis and enhances cell adhesion and invasion in vitro. Cancer Biol Ther 8: 1018-1023.
30. Hedman H, Lindstrom AK, Tot T, Stendahl U, Henriksson R, et al. (2010) LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix. Acta Oncologica 49: 812-815.
31. Zhang H, Yan Q, Xu S, Ou Y, Ye F, et al. (2011) Association of expression of Leucine-rich repeats and immunoglobulin-like domains 2 gene with invasiveness of pituitary adenoma. J Huazhong Univ Sci Technolog Med Sci 31: 520-523.
32. Guo D, Nilsson J, Haapasalo H, Raheem O, Bergenheim T, et al. (2006) Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors. Acta Neuropathol (Berl) 111: 238-246.
33. Holmlund C, Haapasalo H, Yi W, Raheem O, Brannstrom T, et al. (2009) Cytoplasmic LRIG2 expression is associated with poor oligodendroglioma patient survival. Neuropathology 29: 242-247.
34. Stuart HM, Roberts NA, Burgu B, Daly SB, Urquhart JE, et al. (2013) LRIG2 mutations cause urofacial syndrome. Am J Hum Genet 92: 259-264.
35. Wu DK, Kelley MW, (2012) Molecular mechanisms of inner ear development. Cold Spring Harb Perspect Biol 4: a008409.
36. Hilgert N, Smith RJ, Van Camp G, (2009) Function and expression pattern of nonsyndromic deafness genes. Curr Mol Med 9: 546-564.
37. Streeter GL, (1906) On the development of the membranous labyrinth and the acoustic and facial nerves in the human embryo. American Journal of Anatomy 6: 139-165.
38. Mitchell KJ, Pinson KI, Kelly OG, Brennan J, Zupicich J, et al. (2001) Functional analysis of secreted and transmembrane proteins critical to mouse development. Nat Genet 28: 241-249.
39. Kim SH, Marcus DC, (2011) Regulation of sodium transport in the inner ear. Hear Res 280: 21-29.
40. Emmerling MR, Sobkowicz HM, Levenick CV, Scott GL, Slapnick SM, et al. (1990) Biochemical and morphological differentiation of acetylcholinesterase-positive efferent fibers in the mouse cochlea. J Electron Microsc Tech 15: 123-143.
41. Nilsson J, Starefeldt A, Henriksson R, Hedman H, (2003) LRIG1 protein in human cells and tissues. Cell Tissue Res 312: 65-71.
42. Salminen M, Meyer BI, Bober E, Gruss P, (2000) Netrin 1 is required for semicircular canal formation in the mouse inner ear. Development 127: 13-22.
43. Rabbitt RD, Brownell WE, (2011) Efferent modulation of hair cell function. Curr Opin Otolaryngol Head Neck Surg 19: 376-381.
44. Gumienny TL, Macneil L, Zimmerman CM, Wang H, Chin L, et al. (2010) Caenorhabditis elegans SMA-10/LRIG is a conserved transmembrane protein that enhances bone morphogenetic protein signaling. PLoS Genet 6: e1000963.
45. Leighton PA, Mitchell KJ, Goodrich LV, Lu X, Pinson K, et al. (2001) Defining brain wiring patterns and mechanisms through gene trapping in mice. Nature 410: 174-179.
46. Maison SF, Usubuchi H, Liberman MC, (2013) Efferent feedback minimizes cochlear neuropathy from moderate noise exposure. J Neurosci 33: 5542-5552.
47. Schneider CA, Rasband WS, Eliceiri KW, (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9: 671-675.